Navigation Links
Novation Releases its Drug Price Forecast for 2012-13
Date:3/26/2012

IRVING, Texas, March 26, 2012 /PRNewswire/ -- Novation, the leading health care supply contracting company, today announces the release of its Drug Price Forecast Summary Report, Winter 2012.  This summary report highlights key insights offered in Novation's full Drug Price Forecast, including projected drug price inflation summary projections and overviews of the top five therapeutic categories based on purchase volume.

Novation's semi-annual Drug Price Forecast is designed to offer information and support resources to aide in the development of annual drug budget projections. The full report, available exclusively to members of VHA, UHC and Provista, features additional information including:

  • detailed category overviews for the top twelve therapeutic categories based on purchase volume;
  • price inflation projections by product and therapeutic category; and
  • an interactive Drug Budget Worksheet enabling the addition of a facility's purchase history by generic product or therapeutic category to build a pharmaceutical budget for using Novation Drug Price Forecast projections.

Novation's Drug Price Forecast estimates the change in the cost of pharmaceuticals purchased from July 1, 2012, through June 30, 2013. The forecast is focused on pharmaceutical use in the acute care hospital setting and is based on purchase history and data associated with Novation Pharmacy Program participant health care organizations.

The summary report specifically reviews the therapeutic categories of antineoplastics, plasma critical care products, hematopoietic agents, disease-modifying anti-rheumatic drugs, and heparins.

"As hospitals are squeezed more and more tightly by today's financial pressures, the projections in our report can be very helpful for making budget projections," said David Jameson, vice president, pharmacy, Novation.  "Many factors affect the financial predictions in this report.  For example, the number of competitors in the market and the approval and adoption of new drugs are both factors that can have a significant impact on pharmaceutical pricing."

"Ultimately, we want to provide as much information as possible to the members we serve to help them manage their supply costs and understand the emerging pharmaceutical trends," said Jameson.

To view the summary report, please visit https://www.novationco.com/pressroom/industry_info.  VHA, UHC and Provista members may access the full Drug Price Forecast report at Marketplace|Procure.

About Novation, Winner of the Ethics Inside® Certification
Founded in 1998, Novation is the leading health care supply contracting company for the more than 65,000 members of VHA Inc. and UHC, two national health care alliances, and Provista, LLC. Novation provides alliance members sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 600 suppliers. VHA, UHC and Provista members used Novation contracts to purchase more than $40 billion in 2011. Novation recently earned the coveted Ethics Inside® Certification from the Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance, and is the only health care GPO to earn this distinction.


'/>"/>
SOURCE Novation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novation Releases Its Latest Transcatheter Cardiovascular Therapeutics Report to Help Members Understand and Prepare for New Technologies
2. Linet Awarded New Technology Agreement from Novation, the Nations Largest Healthcare Purchasing Organization
3. Clinical Innovation Outsourcing Awards Deadline Extension: Friday 2nd March
4. Lilly Introduces Global Innovation Starts Here Initiative to Foster Innovation and Quality Science
5. Frost & Sullivan New Product Innovation Award Presented to Brainsway for Its Deep Transcranial Magnetic Stimulation (dTMS) Device
6. Novation Applauds New FDA Guidance Documents on Biosimilars
7. Young Innovations, Inc. Announces Record EPS for the Quarter and Record Sales and EPS for the Year
8. Innovation Day 2012: a Time To Inform and Inspire
9. BioParadox Announces Partnership with Fogarty Institute for Innovation
10. Celebrity Chef Danny Boome Announces Launch of Arthriving.com, A New Online Resource Featuring Smart Solutions And Product Innovations For People With Arthritis
11. DLP® LightCrafter™ From Texas Instruments: Enabling Big Innovations In Light Steering From A Compact, Ready-To-Use Module
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017  Zimmer Biomet Holdings, Inc. ... healthcare, today announced that it will be participating in ... at the InterContinental Hotel in Boston, Massachusetts ... will present at 11:20 a.m. Eastern Time. ... via Zimmer Biomet,s Investor Relations website at http://investor.zimmerbiomet.com ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... WOONSOCKET, R.I. , April 20, 2017 /PRNewswire/ ... (NYSE: CVS), today unveiled a new store design ... new assortment of healthier food, health-focused products and ... the store to help customers discover new offerings. ... represent the next evolution of the customer experience ...
Breaking Medicine Technology:
(Date:4/28/2017)... ... 2017 , ... Ushio America proudly introduces the new ... solution for F32T8 fluorescent lamps on most instant-start and programmed-start electronic ballasts so ... lamps utilize the existing electronic ballast, saving labor and maintenance costs. It’s easy ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... announce that Aditya Patel M.D. has joined the revolutionary endoscopic practice under Dr. ... board certification in Interventional Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Texas Cord Blood Bank (TCBB), a program ... delivery team at Women’s Hospital at Renaissance in Edinburg for their outstanding efforts in ... and decide to donate. , “Women’s Hospital at Renaissance has been a collection ...
(Date:4/28/2017)... ... April 28, 2017 , ... Early ... substantially improve drug safety and minimize the cost of development. In this webinar, ... inhibition using cell lines and for cardiac toxicity using induced pluripotent stem cells ...
(Date:4/28/2017)... ... 2017 , ... Bill Howe started his sewer and drain company in 1980 ... joined the team, the Bill Howe brand was born and they began cultivating their ... back to the San Diego community in which they worked, lived and were raising ...
Breaking Medicine News(10 mins):